Quantitative Proteomics Analysis of Aberrant Molecular Events in Acute Myeloid Leukemia

 

  Launch in standalone player
 
Air date: Thursday, December 04, 2008, 10:00:00 AM
Category: Proteomics
Runtime: 75 minutes
NLM Title: Quantitative proteomics analysis of aberrant molecular events in acute myeloid leukemia [electronic resource] / Jarrod A. Marto.
Author: Marto, Jarrod A.
National Institutes of Health (U.S.). Proteomics Interest Group.
Publisher: [Bethesda, Md. : National Institutes of Health, 2008]
Abstract: (CIT): Acute myeloid leukemia (AML) remains a highly lethal malignancy with limited therapeutic options. Full transformation in AML requires coupling of aberrant molecular events associated with multiple cellular processes. For example, mutation of the FLT-3 receptor tyrosine kinase is frequently observed in AML and drives abnormal proliferation. Signaling from oncogenic FLT-3 phosphorylates the transcription factor C/EBP [alpha] and leads to disrupted myeloid differentiation. We are using iTRAQ-based quantitative proteomics approaches to explore divergent signaling downstream of two common FLT-3 mutants, and to monitor remodeling of C/EBP [alpha] protein complexes between transcriptionally competent and repressed states. Representative proteomics data and biochemical results will be described, in addition to and methodological improvements in proteomics-related technologies.
Subjects: Leukemia, Myeloid, Acute--genetics
Models, Molecular
Proteomics--methods
fms-Like Tyrosine Kinase 3--genetics
Publication Types: Government Publications
Lectures
NLM Classification: QZ 350
NLM ID: 101493100
CIT File ID: 14811
CIT Live ID: 7331
Permanent link: http://videocast.nih.gov/launch.asp?14811